Company intelligence / Profile preview
BioPartners Holdings
Baar, Zug, Switzerlandbiopartners.ch ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BioPartners is a Swiss-based biopharmaceutical company that specializes in the development and commercialization of biosimilar versions of complex biological medicines. Founded in 2000, the company was a pioneer in the European biosimilar landscape, achieving one of the first-ever European approvals for a biosimilar somatropin (Valtropin). Its portfolio has historically focused on recombinant proteins, including biosimilar versions of interferon beta-1a and interferon alpha-2a. In 2007, BioPartners was acquired by the Polish pharmaceutical company Bioton S.A., which utilized the acquisition to expand its presence in the global biologics and biosimilars market.
- Therapeutic areas
- EndocrinologyNeurologyInfectious Diseases
- Modalities
- Recombinant proteinBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
LG Life SciencesRentschler Biotechnologie
Beyond the preview
Go deeper on BioPartners Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioPartners Holdings.